Atrial Fibrillation Market 2016: Global Industry Insights, Statistics, Study and Forecasts to 2022
Latest industry research report on Atrial fibrillation (AF) is a type Of arrhythmia which is characterized by poor blood flow in the body due to an irregular and rapid heart rate. The geriatric population is generally more susceptible to this disease. Promising results in clinical trials for combination treatment for atrial fibrillation boosts the growth Of the global atrial fibrillation market. C.R. Bard, Inc., Becton Dickinson & company, Baxter International, Inc., St. Jude Medical, Inc. Bristol-Myers Squibb Corporation, Johnson &...
View full press release